Faiz Kayyem Jon's Insider Trades & SAST Disclosures
Faiz Kayyem Jon's most recent trade in Inhibrx Biosciences Inc. was a trade of 500,000 Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Faiz Kayyem Jon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2024 | 500,000 | 509,360 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2024 | 250,000 | 250,000 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2024 | 250,000 | 250,000 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 52,000 | 1,009,360 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 14.23 per share. | 19 Nov 2024 | 34,843 | 51,093 | - | 14.2 | 495,708 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 14.23 per share. | 19 Nov 2024 | 34,843 | 51,093 | - | 14.2 | 495,708 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 14.19 per share. | 19 Nov 2024 | 18,750 | 69,843 | - | 14.2 | 266,102 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 14.19 per share. | 19 Nov 2024 | 18,750 | 69,843 | - | 14.2 | 266,102 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 89,050 | 1,061,360 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 10,000 | 16,250 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 10,000 | 16,250 | - | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 17.23 per share. | 05 Jun 2024 | 49,284 | 1,142,145 | - | 17.2 | 849,163 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 17.89 per share. | 05 Jun 2024 | 8,265 | 1,150,410 | - | 17.9 | 147,861 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 17.90 per share. | 31 May 2024 | 80,738 | 1,003,798 | - | 17.9 | 1,445,210 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 16.14 per share. | 31 May 2024 | 70,193 | 876,268 | - | 16.1 | 1,132,915 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 17.44 per share. | 31 May 2024 | 65,337 | 1,069,135 | - | 17.4 | 1,139,477 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 16.61 per share. | 31 May 2024 | 46,792 | 923,060 | - | 16.6 | 777,215 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 18.24 per share. | 31 May 2024 | 23,726 | 1,092,861 | - | 18.2 | 432,762 | Common Stock |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 806,075 | 806,075 | - | - | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 6,250 | 6,250 | - | - | Common Stock | |
| Inhibrx Biosciences Inc. | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 6,250 | 6,250 | - | - | Common Stock | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Faiz Kayyem Jon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 105,389 | 134,262 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 6,172 | 180,085 | - | 1.6 | 9,999 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 28,873 | 28,873 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 145,833 | 177,452 | - | - | Common Stock | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 145,833 | 4,878 | - | - | Restricted Stock Units | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 25.26 per share. | 23 Jan 2023 | 9,500 | 3,224,301 | - | 25.3 | 239,999 | Common Stock |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 4,878 | 150,711 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2022 | 31,619 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2022 | 31,619 | 31,619 | - | - | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 26.87 per share. | 21 Dec 2022 | 7,541 | 3,235,760 | - | 26.9 | 202,591 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 27.61 per share. | 21 Dec 2022 | 1,959 | 3,233,801 | - | 27.6 | 54,088 | Common Stock |
| Biodesix Inc | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 21 Nov 2022 | 173,913 | 173,913 | - | 1.2 | 200,000 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 21 Nov 2022 | 6,767 | 3,243,301 | - | 30.1 | 203,819 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 29.33 per share. | 21 Nov 2022 | 2,733 | 3,250,068 | - | 29.3 | 80,153 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 30.58 per share. | 21 Oct 2022 | 5,928 | 3,252,801 | - | 30.6 | 181,255 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Sale of securities on an exchange or to another person at price $ 29.39 per share. | 21 Oct 2022 | 3,572 | 3,258,729 | - | 29.4 | 104,977 | Common Stock |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2022 | 11,900 | 3,262,301 | - | 0 | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2022 | 3,400 | 3,274,201 | - | 0 | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2022 | 118,500 | 3,277,601 | - | 0 | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2022 | 25,000 | 25,000 | - | 0 | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2022 | 25,000 | 25,000 | - | 0 | Common Stock | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,000 | 47,259 | - | - | Stock Option (right to buy) | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 50,368 | 50,368 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 31,619 | 31,619 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 27,038 | 27,038 | - | - | Stock Options (Right to Buy) | |
| Inhibrx Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 15,000 | 32,259 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges